Literature DB >> 20184394

TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.

Yumiko Kanno1, Daisuke Sakurai, Hidenori Hase, Hidefumi Kojima, Tetsuji Kobata.   

Abstract

B-cell-activating factor of the TNF family (BAFF) is a critical factor for B-cell survival and maturation through non-canonical nuclear factor kappaB (NF-kappaB) pathway, a NF-kappaB inducing kinase (NIK)-dependent pathway for the processing of NF-kappaB2 p100 to generate p52. While BAFF acts primarily through BAFF receptor (BAFF-R), the transmembrane activator and CAML interactor (TACI), the other receptor for BAFF, is thought to serve as a negative regulator for B-cell responses. However, how TACI regulates NF-kappaB2 activity is largely unknown. In this study, we showed that constitutive activation of TACI signaling suppressed BAFF-R-mediated NF-kappaB2 p100 processing with the up-regulation of cellular inhibitors of apoptosis 1 (cIAP1) and TNF receptor associated factor (TRAF)-associated NF-kappaB activator (TANK). The ubiquitination of NIK by cIAP1 was inhibited by the expression of TRAF2 with physical binding to cIAP1. TANK deficiency by small interfering RNA (siRNA) impaired TACI-dependent inhibition of NF-kappaB2 p100 processing. TANK also inhibited TRAF2-mediated cIAP1 inactivation. Moreover, the recruitment of TRAF2 to TACI induced the ubiquitination of NIK. Taken together, the regulation of NIK by TACI through the interaction of TANK/TRAF2/cIAP1 plays a pivotal role in the suppression of non-canonical NF-kappaB signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20184394     DOI: 10.3109/10799891003634509

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  7 in total

Review 1.  Regulation of nuclear factor-κB in autoimmunity.

Authors:  Shao-Cong Sun; Jae-Hoon Chang; Jin Jin
Journal:  Trends Immunol       Date:  2013-02-20       Impact factor: 16.687

2.  Heterozygosity for transmembrane activator and calcium modulator ligand interactor A144E causes haploinsufficiency and pneumococcal susceptibility in mice.

Authors:  Haifa H Jabara; John J Lee; Erin Janssen; Sumana Ullas; Kyriaki Liadaki; Lilit Garibyan; Halli Benson; Tatyana Sannikova; Richard Bram; Lennart Hammarstrom; Anthony C Cruz; Richard Siegel; John Manis; Richard Malley; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2016-09-05       Impact factor: 10.793

3.  TACI deficiency enhances antibody avidity and clearance of an intestinal pathogen.

Authors:  Shoichiro Tsuji; Lucas Stein; Nobuhiko Kamada; Gabriel Nuñez; Richard Bram; Bruce A Vallance; Ana E Sousa; Jeffrey L Platt; Marilia Cascalho
Journal:  J Clin Invest       Date:  2014-10-01       Impact factor: 14.808

4.  The design and characterization of receptor-selective APRIL variants.

Authors:  Fiona C Kimberley; Almer M van der Sloot; Marco Guadagnoli; Katherine Cameron; Pascal Schneider; J Arnoud Marquart; Miranda Versloot; Luis Serrano; Jan Paul Medema
Journal:  J Biol Chem       Date:  2012-09-07       Impact factor: 5.157

Review 5.  Emerging Roles for Noncanonical NF-κB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology.

Authors:  Dylan K McDaniel; Kristin Eden; Veronica M Ringel; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

Review 6.  Effect of TACI signaling on humoral immunity and autoimmune diseases.

Authors:  Yi Zhang; Jun Li; Ya-Min Zhang; Xiao-Ming Zhang; Juan Tao
Journal:  J Immunol Res       Date:  2015-03-17       Impact factor: 4.818

7.  TACI Isoforms Regulate Ligand Binding and Receptor Function.

Authors:  Yolanda Garcia-Carmona; Adrian T Ting; Lin Radigan; Sai Krishna Athuluri Divakar; Jose Chavez; Eric Meffre; Andrea Cerutti; Charlotte Cunningham-Rundles
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.